Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

RemeGen Collaborates with Innovent Bio

Monday, July 10, 2023

The collaboration between RemeGen and Innovent Biologics focuses on conducting clinical trials to explore combination therapies using the novel antibodydrug conjugates ADCs RC and RC along with the PD inhibitor sintilimab injection TYVYT

Eisai and Biogen Announce the Traditional Approval for LEQEMBI® (lecanemab-irmb)

Friday, July 07, 2023

Eisai and Biogen announced that the US Food and Drug Administration FDA has approved the supplemental Biologics Licence Application sBLA for LEQEMBI lecanemabirmb mgmL injection for intravenous use

Astellas Pharma Announce Priority Review of US FDA Licence Application for Zolbetuxima

Friday, July 07, 2023

Astellas Pharma made an announcement confirming that the US Food and Drug Administration FDA has accepted the Biologics Licence Application BLA for zolbetuximab and granted it Priority Review status

INOVIQ and Promega Enter into Global Joint Marketing Agreement

Friday, July 07, 2023

INOVIQ and Promega announced a joint marketing agreement aimed at comarketing INOVIQs EXONET exosome capture technology and Promegas Nucleic Acid purification systems on a global scale

TiumBio and Hansoh Pharma Announce Clinical Trial Approval of HS-10518/TU2670

Thursday, July 06, 2023

TiumBio and Hansoh Pharmaceutical Group announced that the China National Medical Products Administration NMPA has granted approval for Hansohs Investigational New Drug IND application for the clinical study of HS also known as TU

SK Bioscience-Government Pharmaceutical Organisation Signed a Memorandum of Understanding

Thursday, July 06, 2023

SK bioscience and the Government Pharmaceutical Organisation GPO have signed a Memorandum of Understanding MOU to strengthen Thailands vaccine infrastructure

Biocytogen Pharmaceuticals and Pheon Therapeutics Announced a License Agreement

Thursday, July 06, 2023

Biocytogen Pharmaceuticals announced a licence agreement with Pheon Therapeutics regarding the development and commercialisation of an antibody

Jacobio Pharma Receives Centre for Drug Evaluation Approval for Pivotal Study of Glecirasib in Pancreatic Cancer

Wednesday, July 05, 2023

Jacobio Pharma announced the approval of novel KRAS GC inhibitor glecirasib for a pivotal study in pancreatic cancer by the Centre for Drug Evaluation CDE

InnoCare Pharma Announces First Clinical Trial of TYK2 Allosteric Inhibitor ICP-488 in China

Wednesday, July 05, 2023

InnoCare Pharma announced that the first patient with psoriasis has received a dosage of ICP their TYK JH allosteric inhibitor in a clinical trial conducted in China

RareStone Group Received Approval for Pitolisant (Wakix) by China's NMPA

Wednesday, July 05, 2023

RareStone Group recently announced that the Chinese National Medical Products Administration NMPA has approved pitolisant also known as Wakix for the treatment of excessive daytime sleepiness EDS or cataplexy in adult patients with narcolepsy